Currently the Enterprise Value (EV) is not available for Aziyo Biologics.
n/a
n/a
n/a
n/a
Financial Position
The company has a current ratio of 0.69,
with a Debt / Equity ratio of -0.65.
0.69
0.59
-0.65
-0.85
-1.33
-7.46
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
n/a
n/a
n/a
$161.42K
$-357.28K
151
0.67
3.49
Taxes
7K
-0.01%
Stock Price Statistics
The stock price has increased by 7.19% in the
last 52 weeks. The beta is -0.08, so Aziyo Biologics's
price volatility has been lower than the market average.
-0.08
7.19%
1.55
2.62
48.31
432,734
Income Statement
In the last 12 months, Aziyo Biologics had revenue of 24.38M
and earned -53.95M
in profits. Earnings per share was -1.86.